Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 23,498 shares at $234.74 ($5.5M) on 2026-01-20, disclosed to the SEC on 2026-01-22.
Scheduled sale ($5.5M) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $234.74 | 23,205 | $5.4M | 98.8% |
| 2 | $235.00 | 293 | $69K | 1.2% |
| Total | $234.74 avg | 23,498 | $5.5M | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |